Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis.
Paller AS, Siegfried EC, Cork MJ, Wollenberg A, Arkwright PD, Gonzalez ME, Lockshin B, Chen Z, Bansal A, Levit NA, Prescilla R. Paller AS, et al. Paediatr Drugs. 2023 Jan;25(1):67-77. doi: 10.1007/s40272-022-00553-8. Epub 2022 Dec 19. Paediatr Drugs. 2023. PMID: 36529811 Free PMC article. Clinical Trial.
Etanercept treatment for children and adolescents with plaque psoriasis.
Paller AS, Siegfried EC, Langley RG, Gottlieb AB, Pariser D, Landells I, Hebert AA, Eichenfield LF, Patel V, Creamer K, Jahreis A; Etanercept Pediatric Psoriasis Study Group. Paller AS, et al. N Engl J Med. 2008 Jan 17;358(3):241-51. doi: 10.1056/NEJMoa066886. N Engl J Med. 2008. PMID: 18199863 Free article. Clinical Trial.
Long-term etanercept in pediatric patients with plaque psoriasis.
Paller AS, Siegfried EC, Eichenfield LF, Pariser D, Langley RG, Creamer K, Kricorian G. Paller AS, et al. J Am Acad Dermatol. 2010 Nov;63(5):762-8. doi: 10.1016/j.jaad.2010.04.004. Epub 2010 Jun 3. J Am Acad Dermatol. 2010. PMID: 20605256 Clinical Trial.
Intermittent etanercept therapy in pediatric patients with psoriasis.
Siegfried EC, Eichenfield LF, Paller AS, Pariser D, Creamer K, Kricorian G. Siegfried EC, et al. Among authors: paller as. J Am Acad Dermatol. 2010 Nov;63(5):769-74. doi: 10.1016/j.jaad.2009.10.046. Epub 2010 Sep 15. J Am Acad Dermatol. 2010. PMID: 20833444 Clinical Trial.
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.
Luger T, Boguniewicz M, Carr W, Cork M, Deleuran M, Eichenfield L, Eigenmann P, Fölster-Holst R, Gelmetti C, Gollnick H, Hamelmann E, Hebert AA, Muraro A, Oranje AP, Paller AS, Paul C, Puig L, Ring J, Siegfried E, Spergel JM, Stingl G, Taieb A, Torrelo A, Werfel T, Wahn U. Luger T, et al. Among authors: paller as. Pediatr Allergy Immunol. 2015 Jun;26(4):306-15. doi: 10.1111/pai.12331. Epub 2015 Apr 13. Pediatr Allergy Immunol. 2015. PMID: 25557211 Free PMC article. Review.
Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
Totri CR, Eichenfield LF, Logan K, Proudfoot L, Schmitt J, Lara-Corrales I, Sugarman J, Tom W, Siegfried E, Cordoro K, Paller AS, Flohr C. Totri CR, et al. Among authors: paller as. J Am Acad Dermatol. 2017 Feb;76(2):281-285. doi: 10.1016/j.jaad.2016.09.021. Epub 2016 Nov 14. J Am Acad Dermatol. 2017. PMID: 27855965
Optimizing Clinical Trials for Atopic Dermatitis in Children.
Siegfried EC, Jaworski JC, Eichenfield LF, Hebert AA, Paller AS. Siegfried EC, et al. Among authors: paller as. J Invest Dermatol. 2017 Jun;137(6):1363-1364. doi: 10.1016/j.jid.2017.01.025. Epub 2017 Feb 9. J Invest Dermatol. 2017. PMID: 28189536 Free article. No abstract available.
611 results